Explore more publications!

Eyeballs & Clicks: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Eyeballs & Clicks.

Press releases published on December 8, 2025

AIM Computer Solutions Releases New White Paper on Streamlining SAP EDI Compliance for Tiered Automotive Suppliers
Robotics Technology Market Expected to Reach USD 349.8 Billion by 2032 | 15.2% CAGR Outlook
Bankaool partners with Maccorp to offer payments in 130 currencies
Digital Substation Market Competition Analysis 2025: How Players Are Shaping Growth
Asphalt And Concrete Equipment Market Competition Analysis 2025: How Players Are Shaping Growth
Artificial Intelligence (AI) Visual Inspection System Market Competition Analysis 2025: How Players Are Shaping Growth
Aircraft Insulation Market Competition Analysis 2025: How Players Are Shaping Growth
Solar Charging Station Market to Surge from USD 0.55 Billion (2021) to USD 2.88 Billion by 2031 at 18.5% CAGR
Global Hydrogen Fuel Cell Truck Market Set for Explosive 36% CAGR, Reaching $3.7 Billion by 2032
Market Outlook 2031 : Cargo Shipping Industry Set to Reach $4.2 Trillion
New book Titled 'Copyright' The opening of the seals! Dives even deeper as AI and the Prince of darkness merges
Pneumococcal Vaccine Market to Reach USD $11.9 Billion by 2029 at 6.1% CAGR
PETCO DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Data Privacy Claims on Behalf of Petco Health and Wellness Company, Inc. Customers
Miltenyi Biomedicine stellt die Primäranalyse der zulassungsrelevanten DALY-2-EU-Studie zur Zweitlinientherapie des rezidivierten/refraktären großzelligen B-Zell-Lymphoms auf der 67. Jahrestagung der American Society of Hematology (ASH) vor
Miltenyi Biomedicine presenta el análisis primario del ensayo pivotal DALY 2-EU para el linfoma de células B grandes en recaída/refractario de segunda línea en la 67.ª Reunión Anual de la American Society of Hematology (ASH)
À l’occasion de la 67e réunion annuelle de l’American Society of Hematology (ASH), Miltenyi Biomedicine présente l’analyse primaire de l’essai pivot DALY 2-EU pour le traitement de seconde ligne du lymphome à grandes cellules B en rechute ou réfractair…
Miltenyi Biomedicine מציגה ניתוח ראשוני של ניסוי DALY 2-EU מרכזי לטיפול בהישנות/עמידות לטיפול קו שני של לימפומה של תאי B גדולים בכנס השנתי ה-67 של האגודה האמריקנית להמטולוגיה (ASH…
Miltenyi Biomedicine memaparkan analisis primer dari uji klinis DALY 2-EU yang penting untuk limfoma sel B besar yang kambuh/refraktori pada lini kedua pada Pertemuan Tahunan American Society of Haematology (ASH) ke-67
Miltenyi Biomedicine, 제67회 미국혈액학회(ASH) 연례 학술대회에서 재발/불응성 거대 B세포 림프종 2차 치료용 DALY 2-EU 중추적 임상시험의 주요 분석 결과 발표
ミルテニー・バイオメディスン (Miltenyi Biomedicine)、第67回米国血液学会(American Society of Hematology、ASH)年次総会で再発・難治性大細胞型B細胞リンパ腫の二次治療における極めて重要なDALY…

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions